Vorinostat Completed Phase 1 Trials for Recurrent Colon Cancer / Recurrent Rectal Cancer / Metastatic Colon Cancer / Unspecified Adult Solid Tumor, Protocol Specific / Stage III Colon Cancer / Stage III Rectal Cancer / Stage IV Rectal Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00227513Vorinostat and Bortezomib in Treating Patients With Metastatic or Unresectable Solid Tumors
NCT00324480Vorinostat and Alvocidib in Treating Patients With Advanced Solid Tumors
NCT00287937Vorinostat, Paclitaxel, and Carboplatin in Treating Patients With Advanced or Refractory Solid Tumors
NCT00243100Vorinostat and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors
NCT00331955Vorinostat and Doxorubicin in Treating Patients With Metastatic or Locally Advanced Solid Tumors
NCT00121277Vorinostat and Capecitabine in Treating Patients With Metastatic or Unresectable Solid Tumors
NCT00138177Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors